These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 24026256)
21. Blood pressure and antihypertensive medication profile in a multiethnic Asian population of stable chronic kidney disease patients. Teo BW; Chua HR; Wong WK; Haroon S; Subramanian S; Loh PT; Sethi S; Lau T Singapore Med J; 2016 May; 57(5):267-73. PubMed ID: 27212015 [TBL] [Abstract][Full Text] [Related]
29. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Böhm M; Schumacher H; Teo KK; Lonn EM; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder RE; Sliwa K; Weber MA; Williams B; Yusuf S Lancet; 2017 Jun; 389(10085):2226-2237. PubMed ID: 28390695 [TBL] [Abstract][Full Text] [Related]
30. Effect of intensive blood pressure on the progression of non-diabetic chronic kidney disease at varying degrees of proteinuria. Der Mesropian PJ; Shaikh G; Beers KH; Mehta S; Monrroy Prado MR; Hongalgi K; Mathew RO; Feustel PJ; Salman LH; Perna A; Gosmanova EO J Investig Med; 2021 Jun; 69(5):1035-1043. PubMed ID: 33542071 [TBL] [Abstract][Full Text] [Related]
31. Synergistic association of combined glycemic and blood pressure level with risk of complications in US veterans with diabetes. Gosmanov AR; Lu JL; Sumida K; Potukuchi PK; Rhee CM; Kalantar-Zadeh K; Molnar MZ; Kovesdy CP J Hypertens; 2016 May; 34(5):907-13. PubMed ID: 26928222 [TBL] [Abstract][Full Text] [Related]
32. Association of Systolic Blood Pressure With Dementia Risk and the Role of Age, U-Shaped Associations, and Mortality. van Dalen JW; Brayne C; Crane PK; Fratiglioni L; Larson EB; Lobo A; Lobo E; Marcum ZA; Moll van Charante EP; Qiu C; Riedel-Heller SG; Röhr S; Rydén L; Skoog I; van Gool WA; Richard E JAMA Intern Med; 2022 Feb; 182(2):142-152. PubMed ID: 34901993 [TBL] [Abstract][Full Text] [Related]
33. Mortality implications of lower DBP with lower achieved systolic pressures in coronary artery disease: long-term mortality results from the INternational VErapamil-trandolapril STudy US cohort. Wokhlu A; Smith SM; Gong Y; Handberg EM; Elgendy IY; Bavry AA; Cooper-DeHoff RM; Pepine CJ J Hypertens; 2018 Feb; 36(2):419-427. PubMed ID: 28938338 [TBL] [Abstract][Full Text] [Related]
34. Pretreatment blood pressure as a predictor of 21-year mortality. Perry HM; Miller JP; Baty JD; Carmody SE; Sambhi MP Am J Hypertens; 2000 Jun; 13(6 Pt 1):724-33. PubMed ID: 10912760 [TBL] [Abstract][Full Text] [Related]
35. Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control. Beddhu S; Chertow GM; Cheung AK; Cushman WC; Rahman M; Greene T; Wei G; Campbell RC; Conroy M; Freedman BI; Haley W; Horwitz E; Kitzman D; Lash J; Papademetriou V; Pisoni R; Riessen E; Rosendorff C; Watnick SG; Whittle J; Whelton PK; Circulation; 2018 Jan; 137(2):134-143. PubMed ID: 29021322 [TBL] [Abstract][Full Text] [Related]
36. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial. Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF; Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258 [TBL] [Abstract][Full Text] [Related]
37. Effects of Intensive BP Control in CKD. Cheung AK; Rahman M; Reboussin DM; Craven TE; Greene T; Kimmel PL; Cushman WC; Hawfield AT; Johnson KC; Lewis CE; Oparil S; Rocco MV; Sink KM; Whelton PK; Wright JT; Basile J; Beddhu S; Bhatt U; Chang TI; Chertow GM; Chonchol M; Freedman BI; Haley W; Ix JH; Katz LA; Killeen AA; Papademetriou V; Ricardo AC; Servilla K; Wall B; Wolfgram D; Yee J; J Am Soc Nephrol; 2017 Sep; 28(9):2812-2823. PubMed ID: 28642330 [TBL] [Abstract][Full Text] [Related]
39. Blood pressure and risk of all-cause mortality in advanced chronic kidney disease and hemodialysis: the chronic renal insufficiency cohort study. Bansal N; McCulloch CE; Rahman M; Kusek JW; Anderson AH; Xie D; Townsend RR; Lora CM; Wright J; Go AS; Ojo A; Alper A; Lustigova E; Cuevas M; Kallem R; Hsu CY; Hypertension; 2015 Jan; 65(1):93-100. PubMed ID: 25287404 [TBL] [Abstract][Full Text] [Related]
40. Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study). Van der Niepen P; Woestenburg A; Brié H; Vancayzeele S; MacDonald K; Denhaerynck K; Lee C; Hermans C; Abraham I Ann Pharmacother; 2009 May; 43(5):849-61. PubMed ID: 19351876 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]